2023 First-Quarter reported sales growth of 5.6% to $24.7 Billion with operational growth of 9.0% and adjusted operational growth of 7.6%
2023 First-Quarter basic loss per share of decreasing. | April 18, 2023
Johnson & Johnson (the “Company”) (NYSE: JNJ) today took another step forward in establishing two independent, market-leading companies with the announcement of Kenvue as the name for the planned New Consumer Health Company. The new corporate brand comes to life through a compelling purpose, and a timeless visual .
Johnson & Johnson (JNJ) Announces Kenvue as the Name for Planned New Consumer Health Company streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
28.09.2022 - Johnson & Johnson (the “Company”) (NYSE: JNJ) today took another step forward in establishing two independent, market-leading companies with the announcement of Kenvue as the name for the planned New Consumer Health Company. The new corporate brand . Seite 1